Apomorphine Hydrochloride Hemihydrate

4 trials 3 recruiting NNeurology/Psychiatry

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

3 Recruiting

0 Completed trials

4 Sponsors

4 Countries

Phase II

Phase I/II

Phase I (Other)

Phase II: 2 Phase I/II: 1 Phase I (Other): 1

Indications tested

Parkinson's disease 1

Sponsors using this IMP

Rigshospitalet 2 CHU De Liege 1 Stichting Radboud University Medical Center 1 Universite De Liege 1

All trials

4 total

Boosting recovery through excitation of arousal and awareness in comatose patients (BREA2KTHROUGH) Not authorised

2023-503617-30-01 Phase I/II 1 country Rigshospitalet
Management of Parkinson's disease if levodopa is broken down prematurely Recruiting

2024-510629-24-00 Phase II 1 country Stichting Radboud University Medical Center
Boosting recovery through excitation of arousal and awareness in comatose patients: Dose finding study (BREA2KTHROUGH DOSEFINDER) Recruiting

2023-503617-30-02 Phase I (Other) 1 country Rigshospitalet
Treating severe brain-injured patients with apomorphine Recruiting

2023-504631-40-01 Phase II 2 countries CHU De Liege; Universite De Liege

Showing 1–4 of 4 trials

← All drugs A–Z